HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bo Peng Selected Research

sintilimab

1/2022Clinical and biomarker analyses of sintilimab versus chemotherapy as second-line therapy for advanced or metastatic esophageal squamous cell carcinoma: a randomized, open-label phase 2 study (ORIENT-2).
1/2021Assessment of TMB, PD-L1, and lymphocyte to monocyte ratio as predictive potential in a phase Ib study of sintilimab in patients with advanced solid tumors.
8/2020Safety and efficacy of sintilimab combined with oxaliplatin/capecitabine as first-line treatment in patients with locally advanced or metastatic gastric/gastroesophageal junction adenocarcinoma in a phase Ib clinical trial.
4/2020Circulating tumor DNA predicts response in Chinese patients with relapsed or refractory classical hodgkin lymphoma treated with sintilimab.
11/2019Durable blockade of PD-1 signaling links preclinical efficacy of sintilimab to its clinical benefit.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Bo Peng Research Topics

Disease

111Neoplasms (Cancer)
07/2022 - 01/2003
57Infections
01/2022 - 09/2002
22Neoplasm Metastasis (Metastasis)
01/2022 - 12/2011
21Inflammation (Inflammations)
05/2022 - 07/2012
18Bacterial Infections (Bacterial Infection)
01/2022 - 01/2008
16Renal Cell Carcinoma (Grawitz Tumor)
05/2022 - 09/2008
12Urinary Bladder Neoplasms (Bladder Cancer)
01/2021 - 09/2010
11Breast Neoplasms (Breast Cancer)
12/2020 - 05/2004
10Prostatic Neoplasms (Prostate Cancer)
11/2021 - 04/2011
10Hepatocellular Carcinoma (Hepatoma)
11/2020 - 07/2010
9Carcinogenesis
07/2021 - 05/2014
8Parkinson Disease (Parkinson's Disease)
01/2021 - 08/2004
8Virus Diseases (Viral Diseases)
01/2021 - 11/2012
7Fibrosis (Cirrhosis)
05/2022 - 04/2013
7Pneumonia (Pneumonitis)
03/2022 - 09/2019
7Carcinoma (Carcinomatosis)
11/2021 - 06/2010
6Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
11/2021 - 09/2012
6Endometriosis
10/2020 - 04/2016
5Adenocarcinoma of Lung
06/2022 - 01/2021
5Cognitive Dysfunction
01/2022 - 07/2009
5Esophageal Squamous Cell Carcinoma
01/2022 - 11/2013
5Alzheimer Disease (Alzheimer's Disease)
01/2022 - 07/2012
5Wounds and Injuries (Trauma)
12/2020 - 03/2012
5Human Influenza (Influenza)
01/2019 - 09/2010
5Reperfusion Injury
04/2018 - 07/2011
4Graft vs Host Disease (Graft-Versus-Host Disease)
10/2022 - 08/2018
4Ischemic Stroke
05/2022 - 06/2019
4Chronic Kidney Failure (Chronic Renal Failure)
03/2022 - 01/2020
4Pathologic Processes
03/2022 - 01/2013
4COVID-19
05/2021 - 06/2020
4Squamous Cell Carcinoma of Head and Neck
01/2021 - 03/2011
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 07/2014
4Pancreatic Neoplasms (Pancreatic Cancer)
09/2020 - 01/2013
4Neurodegenerative Diseases (Neurodegenerative Disease)
12/2019 - 07/2012
4Ischemia
04/2018 - 07/2011
4Lung Neoplasms (Lung Cancer)
03/2017 - 07/2014
4Nephrolithiasis
03/2014 - 01/2014
4Hepatitis B
03/2014 - 11/2012
3Hypertension (High Blood Pressure)
01/2022 - 01/2021
3Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2022 - 12/2018
3Neuroinflammatory Diseases
01/2022 - 10/2017
3Melanoma (Melanoma, Malignant)
01/2022 - 10/2013
3Asthma (Bronchial Asthma)
01/2022 - 01/2016
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
11/2021 - 11/2010
3Adenocarcinoma
01/2021 - 07/2016

Drug/Important Bio-Agent (IBA)

49Proteins (Proteins, Gene)FDA Link
01/2022 - 09/2002
36Biomarkers (Surrogate Marker)IBA
06/2022 - 05/2009
24Pharmaceutical PreparationsIBA
06/2022 - 05/2009
16RNA (Ribonucleic Acid)IBA
05/2022 - 12/2013
13AntigensIBA
01/2022 - 09/2009
13Anti-Bacterial Agents (Antibiotics)IBA
01/2022 - 12/2012
12VaccinesIBA
11/2021 - 09/2009
10MicroRNAs (MicroRNA)IBA
05/2022 - 10/2011
10Messenger RNA (mRNA)IBA
04/2022 - 04/2011
10Cisplatin (Platino)FDA LinkGeneric
10/2021 - 11/2010
10AntibodiesIBA
05/2020 - 04/2011
9Biological ProductsIBA
05/2022 - 01/2014
9Glucose (Dextrose)FDA LinkGeneric
05/2022 - 09/2012
9EnzymesIBA
02/2022 - 01/2010
9DNA (Deoxyribonucleic Acid)IBA
01/2021 - 01/2013
8CytokinesIBA
07/2022 - 01/2014
7Peptides (Polypeptides)IBA
11/2021 - 04/2006
7Antiviral Agents (Antivirals)IBA
01/2021 - 01/2014
7Amino AcidsFDA Link
10/2016 - 12/2011
6Small Interfering RNA (siRNA)IBA
01/2022 - 01/2014
6Indicators and Reagents (Reagents)IBA
01/2022 - 09/2015
6Doxorubicin (Adriamycin)FDA LinkGeneric
01/2022 - 05/2004
6ImmunosorbentsIBA
12/2020 - 09/2012
6sodium-bile acid cotransporterIBA
10/2016 - 11/2012
5sintilimabIBA
01/2022 - 11/2019
5C-Reactive ProteinIBA
01/2022 - 03/2014
5Long Noncoding RNAIBA
01/2021 - 11/2017
5AutoantibodiesIBA
11/2014 - 04/2011
4CateninsIBA
07/2022 - 05/2014
4baicaleinIBA
01/2022 - 10/2017
4LipidsIBA
01/2022 - 04/2014
4Polysaccharides (Glycans)IBA
01/2022 - 01/2014
4baicalinIBA
01/2022 - 10/2017
4Therapeutic UsesIBA
11/2021 - 07/2013
4Liposomes (Liposome)IBA
01/2018 - 01/2014
4Combined VaccinesIBA
01/2018 - 09/2009
3MercuryIBA
09/2022 - 03/2012
3LigandsIBA
07/2022 - 11/2009
3Neuroprotective AgentsIBA
05/2022 - 10/2017
3Oxygen (Dioxygen)IBA
05/2022 - 01/2017
3Blood Glucose (Blood Sugar)IBA
01/2022 - 06/2019
3N-methyladenosineIBA
01/2022 - 01/2021
3InterferonsIBA
12/2021 - 12/2014
3Interleukin-6 (Interleukin 6)IBA
11/2021 - 01/2019
3Silicon Dioxide (Silica)FDA LinkGeneric
06/2021 - 06/2012
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2020 - 12/2012

Therapy/Procedure

42Therapeutics
06/2022 - 01/2008
17Drug Therapy (Chemotherapy)
06/2022 - 05/2004
8Kidney Transplantation
03/2022 - 01/2017
7Radiotherapy
06/2022 - 07/2014
6Immunotherapy
06/2022 - 11/2019
6Prostatectomy (Retropubic Prostatectomy)
01/2021 - 04/2013
6Cystectomy
01/2021 - 02/2011
4Aftercare (After-Treatment)
04/2022 - 12/2009
4Nephrectomy
01/2021 - 09/2008